W

WindMIL Therapeutics

13 employees

WindMIL Therapeutics translates novel insights in bone marrow immunology into life-saving cell therapies for cancer patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical Device

Date founded

2016

Funding rounds raised

Total raised

$33M

from 5 investors over 5 rounds

W

WindMIL Therapeutics raised $33M on June 18, 2018

Investors: Medivate Partners, FoxKiser, Qiming Venture Partners, Domain Associates and Camden Partners

FAQ